Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients

NCT00754364 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

108

Enrollment

OTHER

Sponsor class

Stopped low enrollment rate

Conditions

NSCLC

Interventions

DRUG: Pemetrexed/Carboplatin
DRUG: Gemcitabine

Sponsor

Armando Santoro, MD